title: Presenilin 2 influences miR146 level and activity in microglia.
abstract: Microglia, the resident innate immune cells of the CNS, are the primary defenders against microbes and critical to CNS remodeling. Dysregulation of microglial behavior can lead to unchecked pro-inflammatory activity and subsequent neurodegeneration. The molecular mechanisms leading to chronic inflammation and microglial dysfunction in neurodegenerative diseases are not well-understood. It is known that patients with Presenilin 2 (PS2) mutations develop autosomal dominant Alzheimer disease. We have shown that a lack of normal PS2 function is associated with exaggerated microglia pro-inflammatory responses in vitro. To identify pathways by which PS2 regulates microglia and determine how PS2 dysfunction may lead to altered inflammatory pathways, we pursued an unbiased array approach to assess differential expression of microRNAs between murine PS2 knockout (KO) and wild-type microglia. We identified miR146, a negative regulator of monocyte pro-inflammatory response, as constitutively down-regulated in PS2 KO microglia. Consistent with a state of miR146 suppression, we found that PS2 KO microglia express higher levels of the miR146 target protein interleukin-1 receptor-associated kinase-1, and have increased NFκB transcriptional activity. We hypothesize that PS2 impacts microglial responses through modulation of miR146a. PS2 dysfunction, through aging or mutation, may contribute to neurodegeneration by influencing the pro-inflammatory behavior of microglia. Presenilin 2 (PS2), a membrane associated protease, has been implicated in the pathogenesis of Alzheimer disease. We have previously shown that PS2 plays an important role in curbing the proinflammatory response in microglia. Here, we report the novel finding that PS2 participates in maintaining the basal and cytokine induced expression of the innate immunity regulating microRNA, miR146. These data suggest one mechanism by which PS2 works to reign in proinflammatory microglial behavior and that PS2 dysfunction or deficiency could thus result in unchecked proinflammatory activation contributing to neurodegeneration.
authors: Department of Neurology, University of Washington Medical Center, Seattle, Washington, USA.
authors: Suman
authors: S
authors: Jayadev
authors: Amanda
authors: A
authors: Case
authors: Betty
authors: B
authors: Alajajian
authors: Alison J
authors: AJ
authors: Eastman
authors: Thomas
authors: T
authors: Möller
authors: Gwenn A
authors: GA
authors: Garden
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D053592:Interleukin-1 Receptor-Associated Kinases / Q000235:genetics / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D035683:MicroRNAs / Q000276:immunology / Q000378:metabolism*; D017628:Microglia / Q000166:cytology / Q000276:immunology*; D016328:NF-kappa B / Q000276:immunology / Q000378:metabolism; D053766:Presenilin-2 / Q000235:genetics* / Q000276:immunology; D061251:Primary Cell Culture; D014158:Transcription, Genetic / Q000276:immunology
chemical_list: D035683:MicroRNAs; C534190:Mirn146 microRNA, mouse; D016328:NF-kappa B; D053766:Presenilin-2; C095101:Psen2 protein, mouse; D053592:Interleukin-1 Receptor-Associated Kinases; C507769:Irak1 protein, mouse
keywords: Alzheimer disease; miR146; microglia; neuroinflammation; presenilin
references: Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):403-9
references: 17197420
references: Mol Cell Biol. 2011 Sep;31(17):3584-92
references: 21730286
references: J Alzheimers Dis. 2011;25(1):3-28
references: 21335653
references: PLoS One. 2012;7(2):e31039
references: 22312439
references: Glia. 2013 Jan;61(1):91-103
references: 22653784
references: J Alzheimers Dis. 2010;21(1):1-14
references: 20182045
references: Neuroreport. 2005 May 12;16(7):731-5
references: 15858415
references: J Exp Med. 2011 Jun 6;208(6):1189-201
references: 21555486
references: Neurology. 1996 Aug;47(2):425-32
references: 8757015
references: Annu Rev Immunol. 2012;30:295-312
references: 22224773
references: Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
references: 22296764
references: RNA Biol. 2007 Nov;4(3):131-7
references: 18347435
references: PLoS One. 2010 Dec 29;5(12):e15743
references: 21206757
references: J Biol Chem. 2004 Nov 5;279(45):46907-14
references: 15345711
references: Nature. 2010 Nov 11;468(7321):253-62
references: 21068834
references: Aging Cell. 2012 Feb;11(1):29-40
references: 21981419
references: Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):979-84
references: 18195359
references: Proc Natl Acad Sci U S A. 2011 May 31;108(22):9184-9
references: 21576471
references: Science. 2013 Jan 11;339(6116):156-61
references: 23307732
references: J Biol Chem. 2012 Jun 8;287(24):20356-68
references: 22505716
references: Brain. 2010 Apr;133(Pt 4):1143-54
references: 20375137
references: Biochem Pharmacol. 2010 Dec 15;80(12):1981-91
references: 20599782
references: Am J Pathol. 2002 Jun;160(6):2095-110
references: 12057914
references: Semin Cell Dev Biol. 2009 Apr;20(2):201-10
references: 19073272
references: Trends Immunol. 2012 Sep;33(9):449-58
references: 22721918
references: Science. 1996 Feb 23;271(5252):1128-31
references: 8599092
references: Trends Mol Med. 2011 Nov;17(11):617-24
references: 21795114
references: Cell. 2004 Jan 23;116(2):281-97
references: 14744438
references: J Biol Chem. 2009 Dec 11;284(50):34590-9
references: 19840932
references: J Immunol. 2008 Apr 15;180(8):5689-98
references: 18390754
references: J Immunol. 2000 Apr 15;164(8):4301-6
references: 10754329
references: Curr Top Dev Biol. 2010;92:201-30
references: 20816396
references: J Immunol. 2009 Aug 1;183(3):2150-8
references: 19596990
references: Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
references: 16885212
references: Nat Rev Mol Cell Biol. 2004 Jun;5(6):499-504
references: 15173829
references: Neuron. 2003 Apr 10;38(1):9-12
references: 12691659
references: Nat Rev Immunol. 2011 Mar;11(3):163-75
references: 21331081
references: Adv Pharmacol. 2012;64:127-53
references: 22840746